Office of Research & Development |
|
Project Number: | I01BX004497-01A2 |
| Title: | CCN5 Therapy for Triple Negative Breast Cancer |
| Principal Investigator: | Sushanta K. Banerjee |
| Location: | Kansas City, MO |
| Congressional District Code: | 5 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | October 2019 - March 2024 |
| FY 2024 Funding Amount: | $80,000 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |